Protocol - Perception of Tobacco Product Harm - Cigars
- Perceived Harm of Substance Use
- Perception of Tobacco Product Harm - Cigarettes
- Perception of Tobacco Product Harm - E-Cigarettes
- Perception of Tobacco Product Harm - Pipe Tobacco
- Perception of Tobacco Product Harm - Smokeless Tobacco
Description
This protocol includes questions from Waves 1 and 3 of the Adult Population Assessment of Tobacco and Health Study survey instrument. These specific questions are used to measure a respondent’s perception about the perceived harm of smoking cigars. The three response categories range from less harmful to more harmful.
Specific Instructions
The Smoking Cessation, Harm Reduction, and Biomarkers Working Group recommends categorizing respondents based on the following reported use characteristics: (1) ever user versus never user; (2) current established user, defined as everyday user or some-day user; and (3) former established user according to the Use of Tobacco Products protocol. Polyuse with other tobacco products should be considered as well.
Current and former users might also be categorized based on type of cigar smoked: (1) traditional, (2) cigarillos, and (3) filtered cigars, and whether the cigar brand smoked is tobacco flavor only or other flavors.
Availability
Protocol
Cigars
The next questions are about traditional cigars, cigarillos, and filtered cigars. These products go by lots of different names, so please use these descriptions and photos to understand what they are.
Traditional cigars contain tightly rolled tobacco that is wrapped in a tobacco leaf. Some common brands of cigars include Macanudo®1, Romeo y Julieta®2, and Arturo Fuente®3, but there are many others.
Cigarillos and filtered cigars are smaller than traditional cigars. They are usually brown. Some are the same size as cigarettes, and some come with plastic or wood tips. Some common brands are Black & Mild®4, Swisher Sweets®5, Dutch Masters®6, Phillies Blunts®7, Prime Time®8, and Winchester®9.
1. Have you ever seen or heard of a cigar, cigarillo, or filtered cigar before this study?
[ ] 1 Yes
[ ] 2 No
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: All respondents
[SHOW GENERIC IMAGE OF TRADITIONAL CIGARS, CIGARILLOS, AND FILTERED CIGARS]
2. Which type of cigar have you heard of before this study?
[ ] 1 Traditional cigars like Macanudo®, Romeo y Julieta®, Arturo Fuente®, or others [GO TO Q3]
[ ] 2 Cigarillos or filtered cigars like Black & Mild®, Swisher Sweets®, Dutch Masters®, Phillies Blunts®, Prime Time®, Winchester®, or others [GO TO Q3]
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: Respondents who have seen or heard of a cigar, cigarillo, or filtered cigar (Q1 = 1)
3. Is smoking traditional cigars less harmful, about the same, or more harmful than smoking cigarettes? [SHOW IMAGE OF TRADITIONAL CIGARS]
[ ] 1 Less harmful
[ ] 2 About the same
[ ] 3 More harmful
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: Respondents who have seen or heard of traditional cigars (Q2=1).
4. Is smoking cigarillos less harmful, about the same, or more harmful than smoking cigarettes? [SHOW IMAGE OF CIGARILLOS]
[ ] 1 Less harmful
[ ] 2 About the same
[ ] 3 More harmful
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: Respondents who have seen or heard of cigarillos or filtered cigars(Q2=2).
5. Is smoking filtered cigars less harmful, about the same, or more harmful than smoking cigarettes? [SHOW IMAGE OF FILTERED CIGARS]
[ ] 1 Less harmful
[ ] 2 About the same
[ ] 3 More harmful
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: Respondents who have seen or heard of cigarillos or filtered cigars (Q2=2).
6. How much do you think people harm themselves when they smoke filtered cigars some days but not every day?
[ ] 1 No harm
[ ] 2 A little harm
[ ] 3 Some harm
[ ] 4 A lot of harm
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: All adult respondents.
7. How harmful do you think todays traditional cigars, cigarillos or filtered cigars are compared to those of five years ago?
[ ] 1 Much less harmful
[ ] 2 Somewhat less harmful
[ ] 3 About the same
[ ] 4 Somewhat more harmful
[ ] 5 Much more harmful
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: All adult respondents.
1 General Cigar Co. Inc.
2 Max Rohr, Inc.
3 Fuente Cigar, Ltd.
4 John Middleton Co.
5 Swisher International, Inc.
6 Max Rohr, Inc.
7 Tabacalera Brands, Inc.
8 Prime Time International Distributing, Inc.
9 Lane, Ltd.
Personnel and Training Required
None
Equipment Needs
The PhenX Working Group acknowledges that these questions can be administered in a computerized or noncomputerized format (i.e., paper-and-pencil instrument). Computer software is necessary to develop computer-assisted instruments. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Interviewer-administered questionnaire
Lifestage
Adolescent, Adult
Participants
Adult (aged 18 or older)
Adolescent (aged 12-17)
Selection Rationale
The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products and those at risk for tobacco use across the United States. Respondents aged 12 years or older are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the U.S. Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.
Language
English, Spanish
Standards
Standard | Name | ID | Source |
---|---|---|---|
Human Phenotype Ontology | Addictive behavior | HP:0030858 | HPO |
Derived Variables
None
Process and Review
Not Applicable
Protocol Name from Source
Population Assessment of Tobacco and Health (PATH) Study, PATH Waves 1 and 3 Adult Annotated Instrument, 2016-2018
Source
U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; and U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products, Population Assessment of Tobacco and Health (PATH) Study, 2016, Wave 1 Adult Annotated Instrument, items AG1001, AG9002, AG1099, AG1106, AG1107. Distributed October 21, 2020, by Inter-university Consortium for Political and Social Research, Ann Arbor, MI.
U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; and U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products, Population Assessment of Tobacco and Health (PATH) Study, 2018, Wave 3 Adult Annotated Instrument, items AG9062, AG1110. Distributed October 21, 2020, by Inter-university Consortium for Political and Social Research, Ann Arbor, MI.
General References
Elton-Marshall, T., Driezen, P., Fong, G. T., Cummings, K. M., Persoskie, A., Wackowski, O., Choi, K., Kaufman, A., Strong, D., Gravely, S., Taylor, K., Kwan, J., Bansal-Travers, M., Travers, M., & Hyland, A. (2020). Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Addictive Behaviors, 106, 106337.
Fong, G. T., Elton-Marshall, T., Driezen, P., Kaufman, A. R., Cummings, K. M., Choi, K., Kwan, J., Koblitz, A., Hyland, A., Bansal-Travers, M., Carusi, C., & Thompson, M. E. (2019). U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the PATH Study. Addictive Behaviors, 91, 180-187.
Protocol ID
330503
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX330503_Perception_Risk_Cigars_Cigarillos_Harmful | ||||
PX330503040000 | Is smoking cigarillos less harmful, about more | N/A | ||
PX330503_Perception_Risk_Cigars_Compare_Harmful | ||||
PX330503070000 | How harmful do you think today's traditional more | N/A | ||
PX330503_Perception_Risk_Cigars_Ever | ||||
PX330503010000 | Have you ever seen or heard of a cigar, more | N/A | ||
PX330503_Perception_Risk_Cigars_Filtered_Harmful | ||||
PX330503050000 | Is smoking filtered cigars less harmful, more | N/A | ||
PX330503_Perception_Risk_Cigars_Some_Days_Harmful | ||||
PX330503060000 | How much do you think people harm themselves more | N/A | ||
PX330503_Perception_Risk_Cigars_Traditional_Harmful | ||||
PX330503030000 | Is smoking traditional cigars less harmful, more | N/A | ||
PX330503_Perception_Risk_Cigars_Type | ||||
PX330503020000 | Which type of cigar have you heard of before more | N/A |
Measure Name
Perception of Tobacco Product Harm
Release Date
February 23, 2021
Definition
Instrument used to assess respondents' perception of how much they think people risk harming themselves by using tobacco products and of the relative harm between low-risk products and combustible cigarettes.
Purpose
The purpose of this measure is to collect information from respondents on their thoughts about the physical and health harms associated with using tobacco products. Perceptions of harm of tobacco products are important in predicting first use and continued use.
Keywords
Perceived harm, product harm, Population Assessment of Tobacco and Health, PATH, National Institutes of Health, NIH, U.S. Food and Drug Administration, FDA, Smoking Cessation, Harm Reduction, and Biomarkers, cigarettes, tobacco
Measure Protocols
Protocol ID | Protocol Name |
---|---|
330501 | Perception of Tobacco Product Harm - Cigarettes |
330502 | Perception of Tobacco Product Harm - E-Cigarettes |
330503 | Perception of Tobacco Product Harm - Cigars |
330504 | Perception of Tobacco Product Harm - Pipe Tobacco |
330505 | Perception of Tobacco Product Harm - Smokeless Tobacco |
Publications
There are no publications listed for this protocol.